Alfred Olufemi

1 week ago | law.com | Alfred Olufemi

South Africa’s Supreme Court of Appeal is allowing a $4.2 billion bribery case involving Johannesburg-based MTN to proceed, rejecting jurisdictional defences in a complex telecoms case that involves Iran. Webber Wentzel and Werksmans Attorneys are representing telecoms giant MTN and one of MTN's officials while Honey Attorney and Vasco De Oliveira are advising Netherlands-based East Asian Consortium (EAC), an affiliate of Turkcell, in a dispute that dates back decades.

1 week ago | law.com | Alfred Olufemi

Paul Hastings is representing European energy giant TotalEnergies in a major court case involving the East African Crude Oil Pipeline (EACOP), a $5 billion project that has drawn widespread criticism over environmental and human rights issues. The 1,443 km pipeline, which runs from western Uganda to Tanzania’s Tanga Region, was initially scheduled for completion in 2025.

2 weeks ago | law.com | Alfred Olufemi

The Confederation of African Football (CAF) has settled a long-running investigation into its broadcast deals with Qatari network beIN and French conglomerate Lagardère Group, with Bowmans and Meysan advising different parties. The resolution brings to a close the probe into CAF’s various media and marketing contracts worth over $1.5 billion, launched by the competition commission of the Common Market for Eastern and Southern Africa (COMESA) in 2017.

3 weeks ago | law.com | Alfred Olufemi

ALN and Matouk Bassiouny lawyers have been forced to make swift and painful decisions over the past two years, relocating their teams in Sudan to neighboring countries as violence engulfed the capital city of Khartoum. When attacks intensified in 2024, Egyptian firm Matouk Bassiouny moved its Sudanese partner from Khartoum to Cairo. Other lawyers were transferred to the United Arab Emirates and Saudi Arabia.

3 weeks ago | law.com | Alfred Olufemi

India’s third-largest drug manufacturer, Cipla, has been barred from using a trademark name for an antibiotic drug after a South African court found it too similar to that of a competing product, potentially leading to confusion or deception. On Thursday, Justice James Lekhuleni of the High Court, Western Cape Division, ruled that Cipla’s FURIZOME too closely resembles URIZONE, an antibiotic produced by South African competitor and listed company Adcock Ingram.